Form 4: Axon Director Sells 930 Shares of Common Stock

Axon Enterprise, Inc. Director Caitlin Elizabeth Kalinowski reported the sale of 930 shares of common stock for approximately $535.35 per share.

Summary

• Caitlin Elizabeth Kalinowski, a Director of Axon Enterprise, Inc. (AXON), sold 930 shares of common stock.
• The transaction occurred on February 27, 2026.
• The shares were sold at a weighted average price of $535.3542 per share, with individual trades ranging from $535.17 to $535.65.
• Following this transaction, Kalinowski beneficially owns 3,585 shares of Axon common stock.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it's an insider sale, the disclosure of a Rule 10b5-1 plan suggests a pre-scheduled transaction rather than a reactive one, mitigating negative sentiment.

Negatives

• A director, Caitlin Elizabeth Kalinowski, sold 930 shares of company common stock, which reduces insider ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely disclosed via Form 4 filings. While this specific transaction is a sale, the presence of a Rule 10b5-1 plan suggests it was pre-scheduled and not necessarily indicative of a change in the director's immediate outlook on the company's prospects, distinguishing it from opportunistic selling.

Stakeholder Impact

• Shareholders: May interpret the insider sale differently; some may view it as a routine liquidity event, while others might see it as a slight negative signal, despite the 10b5-1 plan.

Key Dates

Recommendation

The insider sale, while notable, was conducted under a Rule 10b5-1 plan, suggesting it was a pre-scheduled liquidity event rather than a reaction to new material information. Given the relatively small number of shares sold compared to the company's market capitalization and the pre-planned nature, this transaction alone does not warrant a change in investment thesis. A 'hold' recommendation is appropriate as the core fundamentals of Axon Enterprise, Inc. remain unaffected by this routine insider disclosure.

Keywords

Axon Enterprise, AXON, Insider Sale, Form 4, Director Transaction, Caitlin Kalinowski, Stock Sale, Rule 10b5-1